| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-06 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.26 | 1e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |